James George Robinson, Director at NYMOX PHARMACEUTICAL CORP (NYMX), bought 10,000 shares at $1.58 ($16K) on 2019-05-31, disclosed to the SEC on 2019-06-04.
Open-market purchase of $16k NYMX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.58 | 7 | $11 | 0.1% |
| 2 | $1.59 | 8,600 | $14K | 85.9% |
| 3 | $1.60 | 300 | $480 | 3.0% |
| 4 | $1.61 | 1,093 | $2K | 11.1% |
| Total | $1.59 avg | 10,000 | $16K | 100% |
| Filing → |
| NYMX | BUY | 2022-05-06 | $3.8M | — | Filing → |
| NYMX | BUY | 2021-04-27 | $83K | — | Filing → |
| NYMX | BUY | 2019-07-12 | $12K | — | Filing → |